Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag The FDA has reviewed the first module of Implantica AG's application for RefluxStop™, an anti-reflux device.

flag The FDA has accepted and completed its review of Module 1 of Implantica AG's PMA application for RefluxStop™, a device aimed at treating acid reflux. flag This module included quality systems and manufacturing details. flag Before final approval, the FDA will inspect production sites to ensure compliance. flag RefluxStop™, already CE-marked in Europe, aims to revolutionize anti-reflux treatment options.

2 months ago
5 Articles

Further Reading